Additional information
| Active substance | Metformin, Pioglitazone |
|---|---|
| Water Retention | Moderate (Pioglitazone) |
| Hepatotoxicity | Low risk, but monitoring is advised |
| Lab Test | Monitoring of liver function tests, kidney function tests, and blood glucose levels |
| Strength | 15/500mg |
| Also known as | Pioglitazone/Metformin combination |
| Blood pressure | Can potentially lower blood pressure |
| Trade name | Actoplus Met |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | Pioglitazone Hydrochloride, Metformin Hydrochloride |
| Formula | Pioglitazone: C19H20N2O3S В· HCl |
| Substance class | Thiazolidinedione (Pioglitazone), Biguanide (Metformin) |
| Main action | Antidiabetic |
| Half-life | Pioglitazone: 3-7 hours |
| Dosage (medical) | Typically 15-30 mg of Pioglitazone combined with 500-2000 mg of Metformin daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces insulin resistance, decreases glucose production in the liver |
| Side effects | Weight gain, edema, risk of heart failure (Pioglitazone), gastrointestinal disturbances, lactic acidosis (Metformin) |
| Use in sports | Not typically used |
| Manufacturer | USV Pvt. Ltd. |
| Packing | 10 tabs/blister |
Avory Pharma Oxymethelone 10mg 100 Kapseln
Prograf 1mg Astellas Pharma
Tavanic 500 mg Sanofi
Euthyrox 50 mcg MERC
FACTIVE 320 mg Abdi Ibragim
Rovamycine 3.000.000 iu Eczacibasi
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 10 mg Pfizer
Alpha Pharma Alphabol 10 mg 60 Tabletten
Avory Pharma Dianabol 10mg 100 Kapsel
Champix 56 tabs Pfizer 




Reviews
There are no reviews yet.